Solangon, Sarah AnnieVan Wely, MadelonVan Mello, NorahMol, Ben WRoss, Jackie AJurkovic, Davor2023-07-242023-07-242023-09Solangon, S A, Van Wely, M, Van Mello, N, Mol, B W, Ross, J A & Jurkovic, D 2023, 'Methotrexate versus expectant management for treatment of tubal ectopic pregnancy : An individual participant data meta-analysis', Acta Obstetricia et Gynecologica Scandinavica, vol. 102, no. 9, pp. 1159-1175. https://doi.org/10.1111/aogs.146170001-6349unpaywall: 10.1111/aogs.14617https://hdl.handle.net/2164/21290Funding Information: The NL study ran between April 2007 and January 2012 and included 73 women with conclusive ultrasound diagnosis of tubal EP with hCG <1500 IU/L or suspected tubal EP (PUL with plateauing serum hCG) <2000 IU/L. This was funded by a grant of the Netherlands Organization for Health Research and Development (ZonMw Clinical fellow grant 90700154). The UK study ran between August 2005 and June 2014 and included 80 women with conclusive ultrasound diagnosis of tubal EP and a serum hCG <1500 IU/L. This did not receive external funding. Baseline characteristics of intervention and comparison groups were similar and all prespecified outcomes were reported in both studies. Further characteristics of both studies are outlined in Table 1 . 9 11172575715engSDG 3 - Good Health and Well-beingexpectant managementmedical treatmentmethotrexatepregnancy ectopicpregnancy tubalPregnancy, Ectopic/drug therapyHumansPregnancy, Tubal/drug therapyChorionic GonadotropinPregnancyFemaleWatchful WaitingRetrospective StudiesAbortifacient Agents, Nonsteroidal/therapeutic useMethotrexate/therapeutic useRG Gynecology and obstetricsObstetrics and GynaecologyRGJournal item10.1111/aogs.14617http://www.scopus.com/inward/record.url?scp=85163202348&partnerID=8YFLogxK1029